Latest in neurodegeneration research spotlighted at UF-hosted conference
Sessions focused on AI, breathing control, aging and traumatic brain injury — research areas of strength at UF.
Posts tagged as
Frontotemporal Dementia
Neurological Diseases
The McKnight Brain Institute’s signature programs in neurological diseases include brain tumor immunotherapy and a range of neurodegenerative disorders including ALS, Alzheimer’s disease and Parkinson’s disease. The MBI is dedicated to accelerating discoveries in these fields to enhance brain health and develop innovative therapies. 1Florida Alzheimer’s Disease Research Center…
Cognition, Behavior and Sensation
The McKnight Brain Institute’s signature programs in age-related cognitive decline, developmental disorders, sensory dysfunction, pain, and neuropsychiatric diseases including substance use disorders. The MBI is dedicated to accelerating discoveries to enhance brain health and develop innovative therapies. Center for Addiction Research & Education (CARE) CARE facilitates collaborative…
Acquired Neural Injury
The McKnight Brain Institute’s signature programs in acquired neural injury include neural control of respiration, spinal cord injury, stroke and traumatic brain injury. The MBI is dedicated to accelerating discoveries to enhance brain health and develop innovative therapies. Brain Injury, Rehabilitation, and Neuroresilience Center (BRAIN) BRAIN Center…
Neuroprotection Research Snapshot: Drs. Malú Gámez Tansey and Oihane Uriarte Huarte
Progranulin loss results in sex-dependent dysregulation of peripheral and central immune system in mice.
UF neuroscientist to co-lead study into causes of frontotemporal dementia
Under new grant, a research team co-led by Dr. Malú Gámez Tansey will investigate possible links between the immune system and neurodegeneration in frontotemporal dementia.
MBI Rising Stars: Ariel Walker
Ariel Walker is the latest MBI Rising Star, a video series highlighting up-and-coming neuroscience researchers at UF.
Study shows diabetes drug improves symptoms in subtype of ALS in mice
Research led by Drs. Laura Ranum and Tao Zu is encouraging for future treatments for a type of ALS and several other neurological diseases.
New preclinical study shows antibody therapy could offer treatment path for genetic form of ALS
Novel type of immunotherapy used in mouse-model study shows promise for ALS treatment.
Local nonprofit makes gift for dementia research at UF
Barbara Sperrazza was a dietitian and diabetes educator who had the warmest smile and loved to help people. She lost her ability to read, write, speak and eventually swallow due to frontotemporal dementia.
